These data, along with previously published reports, suggest that the increased O-GlcNAc modification of SP1 may contribute to a more stable SP1, which may augment VEGF protein expression and the angiogenic/vasculogenic potential in IPAH vascular cells (Figure 5; Model). The gene discussed is SP1; the disease is idiopathic pulmonary arterial hypertension.